Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
The Federal Trade Commission and seven states asked a federal judge on Tuesday to hold notorious 'Pharma bro' Martin Shkreli in contempt. The FTC and the states allege that Shkreli 'flagrantly and repeatedly violated' a 2022 court order that had…
FTC: 'Pharma bro' Shkreli violated lifetime industry ban, should be held in contempt
The Federal Trade Commission (FTC) and a coalition of seven states asked a federal court on Tuesday to punish Martin Shkreli for “flagrantly and repeatedly” violating a lifetime ban from being involved in the pharmaceutical industry.
Pharma Bro Martin Shkreli Could Be in Big Trouble Again
The Federal Trade Commission has asked a federal judge to hold Martin Shkreli, the former pharmaceutical executive better known as “Pharma Bro” in the 2010s, in contempt of court for allegedly publicly trading in pharmaceutical…
Pharma Has A Blind Spot And It Is Standing Behind The Pharmacy Counter
Harshit Jain, MD, is Founder & Global CEO of Doceree. A pharmaceutical brand will spend years and enormous sums establishing a medicine. Clinical evidence, physician education, patient support, the full apparatus of a modern launch. All of it…
Zealand Pharma Makes Deal With Generate Worth Up to $1.2 Billion
Zealand Pharma A/S is teaming up with Generate Biomedicines Inc. in a billion-dollar deal to develop new obesity treatments using artificial intelligence, expanding the race for the next generation of weight-loss drugs. The Danish biotechnology…
FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban
The Federal Trade Commission and seven state attorneys general say that Martin Shkreli hasn't complied with his lifetime ban from the pharmaceutical industry. In a 37-page court filing, the FTC and the attorneys general state that Shkreli has…
FTC and seven states seek contempt ruling against Shkreli over pharma ban
The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on participating in the pharmaceutical industry, and they are asking a judge to hold him in…
FTC asks judge to find 'Pharma Bro' Martin Shkreli in contempt
Oct. 13 (UPI) -- The Federal Trade Commission and seven states petitioned a federal judge Tuesday to find Martin Shkreli in contempt of court because he allegedly violated a 2022 court order banning him from the pharmaceutical industry. A statement…
UroGen Pharma Stock: An Emerging GARP Stock (NASDAQ:URGN)
UroGen Pharma has pulled back 30% after a 208% rally, driven by Zusduri's strong launch as the only approved non-surgical LG-IR-NMIBC therapy. Zusduri's rapid uptake, favorable patient preference, and robust clinical data support continued growth…
FTC, States Ask Court to Hold 'Pharma Bro' Shkreli in Contempt for Trading Drug Stocks
Federal and state regulators asked a federal judge Tuesday to hold Martin Shkreli in contempt, saying he has traded pharmaceutical stocks on YouTube for years in violation of a lifetime ban from the drug industry. The Federal Trade Commission and…
Pharma company registered at a Falls Church Staples goes public, raises $45M
A Falls Church-based pharmaceutical company has raised $45 million since going public last week, surpassing its original goal. Retension Pharmaceuticals Inc., a 12-person company whose publicly listed address is a Staples store in Falls Church, hit…
Sun Pharma board approves plan to raise up to ₹10,000 cr via NCDs
Sun Pharmaceutical Industries has said its board of directors has approved a proposal to raise funds of up to ₹10,000 crore through the issuance of non-convertible debentures (NCDs). The decision was taken at a meeting of the company's Board…
'Pharma Bro' Martin Shkreli has caught the attention of federal and state authorities again
(CNN) — “Pharma Bro” Martin Shkreli has caught the attention of federal and state authorities again. Since his 2022 release from prison for securities fraud, Shkreli — who gained national notoriety for inflating the…
Pharmalittle: We're reading about concerns over a rare disease drug, pharma payments to docs, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they are happily snoozing in…
Shkreli Faces Contempt for Breaking Pharmaceutical Industry Ban
The Federal Trade Commission and seven states started contempt proceedings against Martin Shkreli, the “Pharma Bro” who served almost seven years in prison for defrauding investors. The FTC said in a statement Tuesday that Shkreli…
Receive a Daily briefing on Pharma Industry News
Get Started